SCHEMBL8505490

SCHEMBL8505490

COc1ccc2c(O[C@@H]3C[C@@H](C(=O)O)N(C(=O)OC(C)C)C3)cc(-c3ccccc3)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 2/20 0.51
TACR3 P29371 8/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PLA2G2A P14555 1/20 0.41
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
HTT P42858 1/20 0.40
HTR3E A5X5Y0 1/20 0.40
HTR3B O95264 1/20 0.40
HTR3A P46098 1/20 0.40
HTR3D Q70Z44 1/20 0.40
HTR3C Q8WXA8 1/20 0.40
CTSB P07858 1/20 0.40
CALCRL Q16602 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4556318 0.90 KDM4E (0.55) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL3045119 0.90 KDM4E (0.54) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL3155976 0.90 KDM4E (0.54) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL2617528 0.89 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL375146 0.89 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL6011641 0.89 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL8261052 0.89 KDM4E (0.50) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL5692686 0.88 KDM4E (0.48) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL3052299 0.86 KDM4E (0.51) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1
SCHEMBL4981286 0.85 KDM4E (0.48) KDM4ESMN1; SMN2ALDH1A1TACR3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881002-A1 HCV NS-3 serine protease inhibitors Tibotec Pharmaceuticals Ltd. (IE) 2008-01-23 EP disclosed